Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Vaccine (4)
141 Articles Available
4
6
Can't find what you're looking for? Try our
advanced search
.
Vaccine
CEPI and GSK Collaborate to Develop a Vaccine for Coronavirus
PR-M02-20-NI-001
VGXI to Manufacture Vaccine Against Novel Coronavirus Under CEPI Funded Collaboration
PR-M01-20-NI-047
Ebola Vaccine
FDA Approves First Vaccine for the Prevention of Ebola Virus Disease
PR-M12-19-NI-035
Vaccine
Gavi Board Approves New Ebola Vaccine Program
PR-M12-19-NI-011
Vaccine Approval
Merck’s ERVEBO® [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Granted Conditional Approval in the European Union
PR-M11-19-NI-011
Vaccine
GSK Candidate Vaccine Demonstrates Sustained Level of Protection Against Active Pulmonary Tuberculosis
PR-M10-19-NI-040
Divest
GSK Agrees to Divest Rabies and Tick-Borne Encephalitis Vaccines to Bavarian Nordic
PR-M10-19-NI-038
Vaccine
Pfizer Announces Positive Preliminary Results from a 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate for Disease Prevention in Infants
PR-M09-19-NI-028
Influenza
Bloomfield Hills Teen Awarded $25,000 for Developing Method to Create Universal Influenza Vaccine
PR-M08-19-NI-060
Vaccine
Uganda Starts its Largest-Ever Ebola Vaccine Trial
PR-M08-19-NI-018
Vaccine
HIV Vaccine to be Tested in the U.S. and Europe
PAO-M08-19-NI-008
Influenza
GSK Ships 2019-20 Seasonal Influenza Vaccines for US Market
PR-M07-19-NI-047
Influenza Vaccine
Seqirus is First-to-Market with U.S. 2019/20 Influenza Vaccines
PR-M07-19-NI-045
M&A
Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform
Emergex Signs an R&D Agreement with IMCB to Develop a Vaccine for the Emerging Threat of Hand, Foot & Mouth Disease
PR-M07-19-NI-031
Vaccine
CDC Advisory Recommends Vaccination of Adults Ages 27-45 with GARDASIL®9 & Harmonization of Catch-up Vaccination for Males and Females Through Age 26
PR-M07-19-NI-004
Drug Development
Mill Creek Life Sciences Receives Grant for Development of Dendritic Cell Vaccine
PR-M06-19-NI-037
Vaccine
Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial
PR-M05-19-NI-074
Vaccine
WuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufacturing Contract
PR-M05-19-NI-070
Vaccines
Moderna Announces Publication of Phase 1 Data for mRNA Vaccines Against Two Potential Pandemic Influenza Strains
PR-M05-19-NI-041
Vaccines
Global Vaccines Market to 2027 - Focus on Influenza, Hepatitis, Respiratory Syncytial Virus, and Other Disease
PR-M05-19-NI-005
Funding
Mymetics receives HIV Vaccine Funding from the NIH
PR-M05-19-NI-004
Vaccine
Measles-Mumps-Rubella Vaccine Available at Rite Aid Pharmacies in Los Angeles California
PR-M04-19-NI-088
Vaccine
Inovio's Ebola Vaccine Delivered Intradermally Demonstrates 100% Immunogenicity in a Clinical Study Published in The Journal of Infectious Diseases
PR-M03-19-NI-072
«
4
6
»
.svg)